FDA Has Its Own Peer Review Process, Gottlieb Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Deputy Commissioner Gottlieb defends agency decision-making practices in face of criticism from medical journals.
You may also be interested in...
Drug Safety Oversight Board Will Require Two-Thirds Majority For Recommendations
FDA's Drug Safety Oversight Board will need a two-thirds majority of a quorum to make recommendations, a Center for Drug Evaluation & Research Manual of Policies & Procedures states
Future BIO Global Efforts Include International Relations, Greenwood Says
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13
Hospira’s Mayne Event: Acquisition Strengthens Oncology Portfolio
Merger will create the leading generic injectable pharmaceutical company in the world.